We demonstrated the mechanisms through which miR-93 inhibits PTEN and CDKN1A, thereby activating proliferation through the c-Met/PI3K/Akt pathway and inhibiting apoptosis in HCC. Here, AKT1 is linked to hepatocellular carcinoma.